Results 61 to 70 of about 296,469 (371)

Management of Hepatitis C–Infected Patients After Sustained Virological Response [PDF]

open access: yesClinical Liver Disease, 2020
Watch an interview with the author Answer questions and earn CME.
openaire   +2 more sources

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment [PDF]

open access: yes, 2010
Background Early detection of nonresponders to hepatitis C therapy limits unnecessary exposure to treatment and its side-effects. A recent algorithm combining baseline anti-NS4a antibodies and on-treatment quantitative PCR identified nonresponders to a ...
de Knegt, Robert J   +8 more
core   +1 more source

Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Who Achieved Sustained Virologic Response.

open access: yesClinical Infectious Diseases, 2019
BACKGROUND Liver fibrosis is an important risk factor for the development of hepatocellular carcinoma (HCC) after sustained virologic response (SVR) in patients with persistent hepatitis C virus (HCV) infection.
H. Toyoda   +5 more
semanticscholar   +1 more source

Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma

open access: yesJGH Open, 2022
Background and Aim The risk of hepatocellular carcinoma (HCC) persists in a condition of sustained virologic response (SVR) after hepatitis C virus (HCV) eradication.
Keishi Sugimachi   +13 more
doaj   +1 more source

Spontaneous Weight Change during Chronic Hepatitis C Treatment: Association with Virologic Response Rates [PDF]

open access: yes, 2013
Objective: We examined weight changes during chronic hepatitis C (CHC) therapy and association with virologic response. Methods: Weight changes were compared between subjects achieving rapid, early, and sustained virologic response rates (RVR, EVR ...
Alashinnawy, Hasan A.   +8 more
core   +1 more source

The Efficacy and Safety of Direct-acting Antiviral Treatment for Chronic Hepatitis C Patients: A Single Center Study

open access: yesThe Korean Journal of Gastroenterology, 2018
Background /Aims: Direct-acting antiviral (DAA) therapy has been shown to achieve a high rate of sustained virologic response (SVR) and favorable outcomes in chronic hepatitis C (CHC) patients.
Seong Jun Park   +5 more
doaj   +1 more source

An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection [PDF]

open access: yesClinical and Molecular Hepatology, 2019
Background/Aims In the Republic of Korea, an estimated 231,000 individuals have chronic hepatitis C virus (HCV) infection. The aim of the present analysis was to evaluate the safety and efficacy of elbasvir/grazoprevir (EBR/GZR) administered for 12 weeks
Youn Jae Lee   +11 more
doaj   +1 more source

Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia. [PDF]

open access: yes, 2017
Hepatitis C virus (HCV) causes mixed cryoglobulinemia (MC) by driving clonal expansion of IgM+CD27+ B cells. These cells display both the features of anergy induced by continual engagement of the B cell receptor (BCR), such as high expression of ...
Casato, Milvia   +7 more
core   +1 more source

Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct‐Acting Antivirals for Hepatitis C

open access: yesHepatology Communications, 2018
Sustained virologic response (SVR) after direct‐acting antiviral (DAA) therapy for chronic hepatitis C results in significant decreases in liver stiffness measured by transient elastography (TE).
Jason J. Pan   +8 more
semanticscholar   +1 more source

Platelet count and sustained virological response in hepatitis C treatment

open access: yesWorld Journal of Hepatology, 2013
To examine the epidemiological data, hematological safety and treatment responses of peginterferon-alpha 2a plus ribavirin therapy for hepatitis C.Between March 2008 and February 2011, 196 hepatitis C virus (HCV) genotype 1 infected Japanese (127 treatment-naive and 69 treatment-experienced patients) patients treated with peginterferon-alpha 2a plus ...
Tatsuo, Kanda   +13 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy